TruDoc Healthcare, GCC’s premier virtual primary care provider, has acquired Wellthy Therapeutics, Asia’s leading clinically validated chronic disease management platform.
This latest move is expected to create new standards in healthcare outcome, quality & patient experience in the region, and heralds TruDoc’s strategic expansion into new markets, including India.
The acquisition of Wellthy Therapeutics’ advanced behavioral science and digital therapeutic solutions with TruDoc’s extensive virtual and in-home healthcare services marks the dawn of a transformative healthcare era. This integration ensures round-the-clock access to high-quality care, tailored treatment plans, and innovative care delivery methods for patients. These advancements hold the potential to greatly enhance health results and streamline healthcare expenditures.
The combined vision is rooted in patient-centric care, aiming to deliver a seamless, integrated healthcare experience that places the patient at the heart of every decision. With TruDoc’s leadership in the GCC and Wellthy’s proven track record in Asia, this alliance is poised to reinforce TruDoc’s leading position in the region as a tech-enabled primary care provider.
“Our founding goal at Wellthy was ambitious, to impact millions of lives. This partnership accelerates our progress towards our impact goal, broadening our reach while enhancing patient outcomes. The combined capabilities are uniquely positioned to significantly lower healthcare expenses, contribute to savings, and reduce unnecessary hospital and clinic visits, while substantially improving the patient experience,” said Abhishek Shah, Founder of Wellthy Therapeutics.
The synergy of TruDoc and Wellthy Therapeutics will enable insurers, employers, and governments to provide high-quality, individualized care. Integrated services offer connected care, remote monitoring, and instant access to healthcare professionals, all supported by AI and personalized care protocols. This approach not only elevates patient care but also delivers validated results in terms of cost reductions across the outpatient care spectrum.
In pursuit of Vision 2025, TruDoc and Wellthy Therapeutics are aligning their clinical strengths and digital health expertise to create a sustainable healthcare ecosystem aimed at impacting 10 million lives. This strategic partnership signifies a significant step towards closing the loop on full-stack primary care, leveraging TruDoc’s clinical proficiency and Wellthy Therapeutics’ prowess in digital health and behavioral science.
